Pages that link to "Q37103190"
Jump to navigation
Jump to search
The following pages link to Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety. (Q37103190):
Displaying 14 items.
- Removing obstacles in neuroscience drug discovery: the future path for animal models (Q28755229) (← links)
- Glutamatergic and GABAergic modulations of ultrasonic vocalizations during maternal separation distress in mouse pups (Q30486159) (← links)
- Astrocytes modulate thalamic sensory processing via mGlu2 receptor activation (Q33825054) (← links)
- Selective Interactions of Valeriana officinalis Extracts and Valerenic Acid with [H]Glutamate Binding to Rat Synaptic Membranes (Q34974640) (← links)
- Post-traumatic stress disorder: emerging concepts of pharmacotherapy (Q34981801) (← links)
- Challenges for translational psychopharmacology research--some basic principles (Q37181782) (← links)
- Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists (Q37775612) (← links)
- Approaches for probing allosteric interactions at 7 transmembrane spanning receptors (Q38082089) (← links)
- Radiosynthesis of carbon-11 and fluorine-18 labelled radiotracers to image the ionotropic and metabotropic glutamate receptors. (Q38166973) (← links)
- Metabotropic glutamate receptor 5 as a potential target for smoking cessation (Q38795082) (← links)
- Neuronal activity patterns in the mediodorsal thalamus and related cognitive circuits are modulated by metabotropic glutamate receptors. (Q41958818) (← links)
- SNARE proteins are essential in the potentiation of NMDA receptors by group II metabotropic glutamate receptors (Q46747485) (← links)
- Positive allosteric modulation reveals a specific role for mGlu2 receptors in sensory processing in the thalamus. (Q48747858) (← links)
- Metabotropic Glutamate Receptor 5 as a Target for the Treatment of Depression and Smoking: Robust Preclinical Data but Inconclusive Clinical Efficacy. (Q52600080) (← links)